Home | Terms of Use | Privacy Statement | Contact Us For U.S. healthcare professionals only.
		Tools and Resources   Video Watch a Biological  Video online...   Biological Activity Video View the biological activity video online. Latest News Latest information about the product. Links Additional resources for medical professionals. Medical Information Submit your clinical questions to medical.info@biovitrum.com Reimbursement Online reimbursement information and materials. ABOUT ORAL MUCOSITIS ABOUT KEPIVANCE® TOOLS AND RESOURCES FOR NURSES FOR PHARMACISTS IMPORTANT PRODUCT SAFETY INFORMATION
	Kepivance® is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support. The safety and efficacy of Kepivance® have not been established in patients with non-hematologic malignancies. Important Safety Information In patients with hematologic malignancies, the most common serious adverse reaction in clinical trials attributed to Kepivance® was skin rash reported in less than 1% of patients.   Contact | Reimbursement | Biovitrum.com | Site Map Prescribing Information © 2008 Biovitrum AB (publ). All rights reserved.